Nab-rapamycin in Combo With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
A phase 1/2 multi-center investigation of ABI-009 (nab-rapamycin) in combination with mFOLFOX6 and Bevacizumab as first-line therapy in patients with advanced or metastatic colorectal cancer
创建时间：
2018-07-15
